Abstract
The exact origin of chronic rhinosinusitis (CRS) is still unknown. The disease is most likely to be caused and maintained by multiple factors. A recent theory suggested fungi to be significantly implicated in the generation of CRS and nasal polyposis (NP). Preliminary reports suggested that topical antifungal treatment improved NP and CRS, whereas randomized, blinded, and placebo-controlled trials did not find antifungal lavages or sprays to be better than saline. Similarly, systemic antifungal treatment did not show any effect on CRS. Despite disappointing clinical trials, there is evidence that amphotericin B efficacy (a) depends upon the dosage and duration used and (b) probably acts via a selective cytotoxic effect on NP cells, rather than its antifungal properties. Whatever the future of amphotericin B in rhinology, one must not forget that this drug has side effects and that extensive use might induce resistances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J et al (2004) Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 54(2):376–385
Bent JP III, Kuhn FA (1996) Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 106(11): 1331–1334
Corradini C, Del Ninno M, Buonomo A, Nucera E, Paludetti G, Alonzi C, Sabato V, Schiavino D, Patriarca G (2006) Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 16(3):188–193
Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ (2006) Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 118(5):1149–1156
Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ (2007) The fungal debate: where do we stand today? Rhinology 45(3):178–189
Fokkens W, Lund VJ, Bachert C, Clement P, Hellings P, Holmstrom M, Jones N, Kalogjera L, Kennedy DW, Kowalski M, Malmberg H, Mullol J, Passali D, Stammberger H, Stierna P (2005) EPOS – European position paper on rhinosinusitis and nasal polyposis. Rhinology Suppl 18:1–88
Fokkens W, Lund V, Mullol J (2007) EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45(2): 97–101
Gosepath J, Grebneva N, Mossikhin S, Mann WJ (2002) Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol 16(1):25–31
Hartsel SC, Benz SK, Ayenew W, Bolard J (1994) Na+, K+ and Cl− selectivity of the permeability pahways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics. Eur Biophys J 23(2): 125–132
Helbling A, Baumann A, Hanni C, Caversaccio M (2006) Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 120(12):1023–1025
Hofer E, Neher A, Schrott-Fischer A, Nagl M (2004) Influence of amphotericin B on the ciliary beat frequency of nasal mucosa. Laryngoscope 114(11):1964–1966
Jen A, Kacker A, Huang C, Anand V (2004) Fluconazole nasal spray in the treatment of allergic fungal sinusitis: a pilot study. Ear Nose Throat J 83(10):693–695
Jornot L, Rochat T, Lacroix JS (2003) Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 41(4):201–205
Jornot L, Rochat T, Caruso A, Lacroix JS (2005) Effects of amphotericin B on ion transport proteins in airway epithelial cells. J Cell Physiol 204(3):859–870
Kennedy, D.W., F.A. Kuhn, D.L. Hamilos, S.J. Zinreich, D. Butler, G. Warsi, P.J. Pfister, and A. Tavakkol, (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope. 115(10):1793–1799
Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74(9): 877–884
Ponikau JU, Sherris DA, Kita H, Kern EB (2002) Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 110(6):862–866
Ponikau JU, Sherris DA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115(1):125–131
Rains BM III, Mineck CW (2003) Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 17(1):1–8
Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS (2002) Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 116(4): 261–263
Rogers TR (2006) Antifungal drug resistance: limited data, dramatic impact? Int J Antimicrob Agents 27(suppl 1):7–11
Shin SH, Ye MK (2004) Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124(10): 1174–1177
Shirazi MA, Stankiewicz JA, Kammeyer P (2007) Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol 21(2):145–148
Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H (2006) Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 132(7):743–747
Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113(6): 1122–1128
Wildfeuer A, Seidl HP, Paule I, Haberreiter A (1998) In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41(7–8):309–319
Yang YL, Li SY, Cheng HH, Lo HJ (2005) The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis 5:99
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Giger, R., Landis, B.N., Stow, N.W., Lacroix, JS. (2010). Antifungal Treatment (Topical/Systemic). In: Önerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-11412-0_24
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11411-3
Online ISBN: 978-3-642-11412-0
eBook Packages: MedicineMedicine (R0)